Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 16.4% in First Half of 2022

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 1.1 billion yuan in the first half of 2022, up 16.4% year-on-year.

Meanwhile, the company posted 3.3 billion yuan in revenue, up 87.6% year-on-year.

At the end of the reporting period, it had 29 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 5.3%.